France · Delayed Price · Currency is EUR IntegraGen Statistics
Total Valuation
IntegraGen has a market cap or net worth of EUR 180,694. The enterprise value is -629,917.
| Market Cap | 180,694 |
| Enterprise Value | -629,917 |
Important Dates
The next estimated earnings date is Monday, April 26, 2027.
| Earnings Date | Apr 26, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
IntegraGen has 6.59 million shares outstanding.
| Current Share Class | 6.59M |
| Shares Outstanding | 6.59M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.05 |
| PB Ratio | -0.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.95
| Current Ratio | 0.95 |
| Quick Ratio | 0.85 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.19 |
| Interest Coverage | -1,473.37 |
Financial Efficiency
Return on equity (ROE) is -629.40% and return on invested capital (ROIC) is -21,127.27%.
| Return on Equity (ROE) | -629.40% |
| Return on Assets (ROA) | -41.35% |
| Return on Invested Capital (ROIC) | -21,127.27% |
| Return on Capital Employed (ROCE) | -21,127.27% |
| Weighted Average Cost of Capital (WACC) | 3.62% |
| Revenue Per Employee | 135,701 |
| Profits Per Employee | -71,996 |
| Employee Count | 37 |
| Asset Turnover | 1.21 |
| Inventory Turnover | 23.72 |
Taxes
| Income Tax | -91,787 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.73% in the last 52 weeks. The beta is 0.52, so IntegraGen's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -81.73% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.17 |
| Relative Strength Index (RSI) | 13.84 |
| Average Volume (20 Days) | 37,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IntegraGen had revenue of EUR 5.02 million and -2.66 million in losses. Loss per share was -0.40.
| Revenue | 5.02M |
| Gross Profit | 1.06M |
| Operating Income | -2.75M |
| Pretax Income | -2.76M |
| Net Income | -2.66M |
| EBITDA | -2.71M |
| EBIT | -2.75M |
| Loss Per Share | -0.40 |
Balance Sheet
The company has 1.12 million in cash and 304,597 in debt, with a net cash position of 810,605 or 0.12 per share.
| Cash & Cash Equivalents | 1.12M |
| Total Debt | 304,597 |
| Net Cash | 810,605 |
| Net Cash Per Share | 0.12 |
| Equity (Book Value) | -908,525 |
| Book Value Per Share | -0.14 |
| Working Capital | -140,634 |
Cash Flow
In the last 12 months, operating cash flow was -1.58 million and capital expenditures -2,266, giving a free cash flow of -1.58 million.
| Operating Cash Flow | -1.58M |
| Capital Expenditures | -2,266 |
| Depreciation & Amortization | 44,703 |
| Net Borrowing | 748,713 |
| Free Cash Flow | -1.58M |
| FCF Per Share | -0.24 |
Margins
Gross margin is 21.14%, with operating and profit margins of -54.82% and -53.05%.
| Gross Margin | 21.14% |
| Operating Margin | -54.82% |
| Pretax Margin | -54.88% |
| Profit Margin | -53.05% |
| EBITDA Margin | -53.93% |
| EBIT Margin | -54.82% |
| FCF Margin | n/a |
Dividends & Yields
IntegraGen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -975.70% |
| FCF Yield | -577.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IntegraGen has an Altman Z-Score of -3.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.23 |
| Piotroski F-Score | 2 |